ezetimibe has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, D; Hirata, Y; Kim-Kaneyama, JR; Kitagawa, T; Kurobe, H; Lei, XF; Masuzaki, H; Okawa, C; Sata, M; Sato, M; Shimabukuro, M; Soeki, T; Sugasawa, N; Takao, S; Tanaka, Y; Uematsu, E; Yagi, S; Yamada, H; Yanagi, S | 1 |
| Diep, F | 1 |
| Darlington, JW; Gershkovich, P; Lee, SD; Wasan, KM | 1 |
| Heinzl, S | 1 |
1 review(s) available for ezetimibe and Cardiac Diseases
| Article | Year |
|---|---|
Inhibition of cholesterol absorption: targeting the intestine.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Atherosclerosis; Azetidines; Bile Acids and Salts; Cholesterol; Ezetimibe; Heart Diseases; Humans; Intestinal Absorption; Liver X Receptors; Molecular Targeted Therapy; Orphan Nuclear Receptors; Phytosterols; Sterol O-Acyltransferase; Transcription, Genetic | 2012 |
3 other study(ies) available for ezetimibe and Cardiac Diseases
| Article | Year |
|---|---|
The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.
Topics: Adipose Tissue, White; Adiposity; Animals; Anticholesteremic Agents; Cardiomegaly; Cholesterol; Ezetimibe; Gastrointestinal Agents; Gene Expression Regulation, Enzymologic; Heart; Heart Diseases; Hydroxycholesterols; Hyperphagia; Intestinal Absorption; Lipoproteins, LDL; Liver; Male; Myocardium; Oxidation-Reduction; Pericardium; Random Allocation; Sus scrofa | 2016 |
Cholesterol conundrum.
Topics: Azetidines; Cholesterol, HDL; Cholesterol, LDL; Ezetimibe; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Niacin; Risk Factors; Stroke | 2011 |
[Horse and rider].
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Ezetimibe; Heart Diseases; Humans; Hypercholesterolemia; Risk Factors | 2006 |